Cyclical edidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis
- 30 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (3) , 235-242
- https://doi.org/10.1016/s0002-9343(99)80154-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- INTERMITTENT CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSSRheumatology, 1994
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993
- Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone lossJournal of Bone and Mineral Research, 1992
- Corticosteroid effects on proximal femur bone lossJournal of Bone and Mineral Research, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- TWO-YEAR FOLLOW-UP OF BIPHOSPHONATE (APD) TREATMENT IN STEROID OSTEOPOROSISThe Lancet, 1988
- Evaluation of factors associated with glucocorticoid‐induced osteopenia in patients with rheumatic diseasesArthritis & Rheumatism, 1985
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983
- The effects of sex steroid and corticosteroid hormones on boneJournal of Steroid Biochemistry, 1981
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.Journal of Clinical Investigation, 1979